Express Pharma

Sanofi sees faster profit growth on Dupixent, flu vaccine

Sanofi reported a 26.5 per cent rise in third-quarter business operating income, or adjusted earnings before interest and tax, to 4.5 billion euros ($4.49 billion), well ahead of an average analyst estimate of 4.17 billion euros

0 269